Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Adenylosuccinic acid (Adenylosuccinate; Aspartyl adenylate) is a purine ribonucleoside monophosphate and plays a role in nucleotide cycle metabolite. Adenylosuccinic acid has the potential for the study of duchenne muscular dystrophy(DMD)[1] and can be converted into fumaric acid through adenylosuccinate lyase.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | 35 days | $ 198.00 | |
10 mg | 35 days | $ 315.00 | |
25 mg | 35 days | $ 643.00 | |
50 mg | 35 days | $ 1,180.00 |
Description | Adenylosuccinic acid (Adenylosuccinate; Aspartyl adenylate) is a purine ribonucleoside monophosphate and plays a role in nucleotide cycle metabolite. Adenylosuccinic acid has the potential for the study of duchenne muscular dystrophy(DMD)[1] and can be converted into fumaric acid through adenylosuccinate lyase. |
In vivo | Adenylosuccinic acid (oral administration; 3-3000 μg/mL; 6 weeks) significantly improves the features of murine DMD. It decreases the number of centronucleated fibres, lipid accumulation, connective tissue infiltration and Ca2+?content of mdx tibialis anterior[1]. |
Synonyms | Aspartyl adenylate, Adenylosuccinate |
Molecular Weight | 463.29 |
Formula | C14H18N5O11P |
CAS No. | 19046-78-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Adenylosuccinic acid 19046-78-7 Others Aspartyl adenylate Adenylosuccinate inhibitor inhibit